Latest filing published 22 Dec 2022 for RTW Biotech Opportunities Ltd, €11k.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 3 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +15.0%Entry US$1.22 · Close at T+365 US$1.40
- -40.3%Entry US$1.97 · Close at T+365 US$1.17
- -13.5%Entry US$1.93 · Close at T+365 US$1.67
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
SAS Family Holdings LLC: trading record in brief
All filings by SAS Family Holdings LLC on record concern RTW Biotech Opportunities Ltd. Over a trading history stretching from 22 December 2020 to 21 December 2022, the count stands at 3 filings.
No open-market sale appears; the market trades are 3 purchases worth €548k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. In 2022 alone, the filings show 1 purchase and no sales.
In size, the median ticket on the buying side is €151k. Clusters matter here: 1 out of 3 purchases overlapped with buying by a colleague within 30 days. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time. Ninety days after publication, 3 purchases show a median change of -10.5%, with the price up in 33% of them. These figures describe past trades and do not predict future prices.
The record was last updated on 22 December 2022 with an open-market purchase (€11k) in RTW Biotech Opportunities Ltd. The median gap between a trade and its publication by RNS (LSE) is 2 days. The regulation allows three business days to notify a trade (UK MAR). This summary is built from RNS (LSE) disclosures alone and does not predict where the share price will go.
Companies and markets linked to SAS Family Holdings LLC
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 10,000 shares@ US$1.182.0% of flowLondon Stock ExchangeISIN GG00BKTRRM22FCA-NSM:4622087Canonical exit: 21 Mar 2023 (T+90)
- 236,996 shares@ US$1.9270.5% of flowLondon Stock ExchangeISIN GG00BKTRRM22FCA-NSM:4115907Canonical exit: 16 Dec 2021 (T+90)
- 100,000 shares@ US$1.8427100.0% of flowLondon Stock Exchange, Specialist Fund SegmentISIN GG00BKTRRM22FCA-NSM:3826424Canonical exit: 22 Mar 2021 (T+90)
3 of 3 declarations